chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Symptoms began little after ten hours of receiving vaccine.  Symptoms included flu like symptoms of aches , joint pain and fatigue with fever up to 101 lasting 3 1/2 days. Fever broke SUnday night 14th, approx 9:00pm.  Awoke Monday the 15th  light headed and fatigued but aches and fever gone. Then approximately 5 pm on Monday the 15th started having chest pain, upper right side.  By midnight I was being transferred to ER for the chest pains. Released Monday morning the 16th from ER Dx. Possible chest wall inflammation; Followed up with primary care office (not my regular Dr. but with Dr. Have been experiencing internal jittering; agitated cough, upper respiratory issues (but lungs are clear.) ever since I originally had Covid.
Pt reported at 6pm he started to feel shaky, chills, joint aches, tired and a headache which all lasted about 24 hours. Also patient reports a 6" diameter circle of redness which is still present today 4/18 10am.
Product temperature excursion issue; A spontaneous report was received from a Medical Assistant concerning 11 patients who received Moderna's COVID-19 vaccine (mRNA-1273) that underwent a product temperature excursion.  The patient's medical history was not provided. Concomitant product use was not provided.  On 18-Feb-2021 or 19-Feb-2021, 11 patients received their second dose of mRNA-1273, intramuscularly for prophylaxis of COVID-19 infection.  On 23-Feb-2021 the reporter called to report an excursion. A vial of mRNA-1273 was in the freezer for 5 hours and reached a maximum temperature of 28 degrees Fahrenheit (F). According to the Healthcare Provider, the vial was half frozen and half liquid state upon visual inspection. A Healthcare Provider took the vial out of the freezer and stored it in the refrigerator at max temperature of 40-41 degrees F. for 4 hours. Then the vial was stored at room temperature for 4 hours. A maximum temperature of 70 F was reached before administering to patients.  The patients received both scheduled doses of mRNA-1273 prior to discovery of the event;  therefore action taken with the drug in response to the event is not applicable.  The outcome of the event, product temperature excursion, was recovered/resolved on an unknown date.; Reporter's Comments: This report refers to a case of Product temperature excursion issue for mRNA-1273, lot # unknown, with no associated AEs.
I started feeling light headed about 15 minutes after the shot and my left arm was swollen and sore. As the course of the day went on I became fatigued and I started having body aches. This lasted through the night and into the next day  finally clearing up after 48 hours. I still am tender at the injection site and there is a large red mark still where I got the shot on March 24 that has not gone away.
Received an extra dose / on accident; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 18-year-old male patient who received HBV (Engerix B) (batch number D423N, expiry date 1st June 2022) for prophylaxis.   Co-suspect products included hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 7th July 2021, the patient received the 4th dose of Engerix B (intramuscular) .5 ml and Engerix B Pre-Filled Syringe Device. On 7th July 2021, unknown after receiving Engerix B and Engerix B Pre-Filled Syringe Device, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. The reporter stated that patient was fully vaccinated with Engerix-B and received an extra dose in accident,which led to extra dose administered. The reporter consented to follow up.
Headache, muscle pain, severe pain, and swollen glands in the armpit (swollen lymph nodes).
Patient had presented to ER on 12/16/2009 for crush injury to right foot - Tetanus toxoid was given. Noted injection was DPT vacc. Weakness in bilateral upper & lower extremities. Babinski signs absent facial paresis, persistent disequilibrium transferred to another hospital
HZ starting in my hands; This is a spontaneous report from a contactable consumer (patient) reported for himself. A 36-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, brand name provided as "Comernity", pending clarification), dose 1 via an unspecified route of administration, administered in Arm Right on 04May2021 10:30 (Lot Number: 1B003A) as 1st dose, single for covid-19 immunisation. The patient medical history was none. No Known Allergies. concomitant medications were not reported. the patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced HZ starting in his hands on 12May2021. the adverse event result in Doctor or other healthcare professional office/clinic visit. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient underwent lab tests and procedures which included Combined nasal throat RT-PCR have proof: negative on 17Apr2021 (Other).  treatment received for the adverse event included AV. outcome of the events was not recovered. It was a serious case, Seriousness criteria of Results in death, Caused/prolonged hospitalization and Congenital anomaly/birth defect were no, Seriousness criteria of Disabling/Incapacitating was yes.  information about lot/batch number was available. Further information was expected.
CHRONIC HYPOXEMIC RESPIRATORY FAILURE 1/10/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
This spontaneous report was received from an office manager and refers to a 5 year-old patient of unknown gender. There was no information about patient's concomitant medications, concurrent conditions or pertinent medical history reported. On 31-OCT-2016, the patient was vaccinated with the first improperly stored dose of VARIVAX, lot number M027885 with an expiration date on 30-JUN-2018 (dose, route and anatomical location was not reported) for prophylaxis. The vaccine was exposed to temperature of 7.7 Fahrenheit (F) during 24 hours. There was no previous temperature excursion. No adverse effects were reported. No data logger was involved. This is one of several reports from the same source. Additional information has been requested.
Headache approximately  8 hours after vaccination. Diarrhea approximately 31 hours after vaccination.
Occasional stabbing pain at the site of injection. Has continued to recur for over 2 years.
No adverse event.  But injection was administered posterior to the center of the deltoid.  It is not clear that it entered the muscle. Patient had some arm pain (now resolved) and had 2 days of typical post-COVID-vaccine symptoms (fatigue -- now resolved)
Sore arm near the injection site, the morning after the 1st dose; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EJ1685) via an unspecified route of administration in the left arm on 01Mar2021 at 02:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medication within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 02Mar2021, the morning after the first dose, the patient experienced sore arm near the injection site. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore arm near the injection site was resolving at the time of this report.  No follow-up attempts are possible. No further information is expected.
legs were heavy and numb; weakness in legs; bladder was now the problem/brain doesn't tell the body to go to the bathroom she is leaking because the bladder is filling up filling over; reason for hospitalization;her kidneys; totally became paralyzed from the waist down; legs were heavy and numb; Patient was a little nervous; painful tingling feeling she have that kind of feeling in her legs; This is a spontaneous report from a contactable consumer (patient's mother) from a Pfizer-sponsored program,. A 39-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 20Apr2021 at 19:30 (Batch/Lot number was not reported) as single dose for covid-19 immunization and pregabalin (LYRICA), via an unspecified route of administration from an unspecified date at 100 mg, 3x/day for neuropathy. Medical history included neuropathy from 2020 and ongoing. The patient's concomitant medications were not reported. It was reported that the patient got the vaccine and she was taking pregabalin as well and after vaccination, she experienced an adverse event, her legs were heavy and numb and also her bladder was now the problem she was actually now at the emergency room. Patient was a little nervous. The patient was still in the hospital and she was not getting any care. What happened at the beginning was that she totally became paralyzed from the waist down, when your foot fall asleep you get painful tingling feeling she have that kind of feeling in her legs not able to move any part of her anywhere from her waist down later on that night, after she took pregabalin, went to sleep about an hour she was able to move her left toes and able to drag one leg a little bit. She was supposed to take pregabalin 3 times a day and they were giving her a difficult time about it, she took one at 12 O' clock on Wednesday and the hospital they did not give another one until 11 o clock that evening because she was supposed to take 3 times a day. After she no longer feel from the waist down, she took a pregabalin and it didn't help her it didn't work and her physician told her to take 3 times a day and then at 10 O' clock yesterday morning she was still asking the hospital to give her another one. When asked to repeat the concern, patient stated "weakness in her legs that felt very heavy like she was dragging. The date of hospitalization was reported as 21Apr2021. The reason for hospitalization was reported as numbness in her legs and weakness in legs, became paralyzed from the waist down, and her kidneys. So her brain doesn't tell the body to go to the bathroom she is leaking because the bladder is filling up filling over and the body doesn't know to get it out its leaking because it is filling up it is so full. The patient underwent lab test in the hospital. The action taken with pregabalin in response to the events was unknown. Outcome of the events was unknown.
still got sick but not quite as badly; This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (still got sick but not quite as badly) in a  patient of an unknown age and gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     Previously administered products included for COVID-19 vaccination: COVID-19 VACCINE (Booster dose) in October 2021, COVID-19 VACCINE (Booster dose) in October 2021, COVID-19 VACCINE (Dose 2 (Original Vaccination)), COVID-19 VACCINE (Dose 1 (Original Vaccination)), COVID-19 VACCINE (Dose 2 (Original Vaccination)) and COVID-19 VACCINE (Dose 1 (Original Vaccination)). Past adverse reactions to the above products included Nausea with COVID-19 VACCINE, COVID-19 VACCINE and COVID-19 VACCINE; and Vomiting with COVID-19 VACCINE, COVID-19 VACCINE and COVID-19 VACCINE.    On an unknown date, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced ILLNESS (still got sick but not quite as badly). At the time of the report, ILLNESS (still got sick but not quite as badly) outcome was unknown.            No concomitant medication was reported.  The patient had the two original vaccinations and one booster for Covid, the last one being October 2021. The patient experienced nausea and vomiting for all three and really took about three days to recover from each shot. The patient tried the Moderna shot last week (Oct 2022) and still got sick but not quite as badly. The patient was wondering if patient had suffered an allergic reaction. The patient did not knewanyone else who got hit from the shots in this way.   No treatment information was provided.
due to get the 2nd dose, but she tested positive for COVID yesterday; due to get the 2nd dose, but she tested positive for COVID yesterday; Dizzy; starting to get foggy; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EH9899 or EH9897), via an unspecified route of administration at the left arm on 04Jan2021 at single dose for COVID-19 immunization. Medical history included ongoing diabetic, blood pressure high, high cholesterol and sore arms from previous vaccines (unspecified).She had energy for a whole week after getting the vaccine, that she has not had for a long time, she even cleaned out her whole garage; has been waiting to do that for 3 years; had to make herself stop to rest. There were no concomitant medications. The patient got her first dose on 04Jan2021 and was due to get the 2nd dose this coming 25Jan2021, but she tested positive for COVID on 21Jan2021. She has been sick for a week which started with an irritating cough on 14Jan2021. She went to the ER because she was dizzy as could be on Jan2021. She does not remember which day; she was starting to get foggy on Jan2021. She was not admitted. She did a drive through rapid test on 21Jan2021 and it was positive. Lot numbers: Handwriting on her card was bad and she cannot tell if the last digit of the Lot number is a 9 or 7. The vaccine was administered in an open tent clinic outside  in a parking lot outside a hospital and not in a military facility. The outcome of the event was unknown.   Information on Lot/Batch has been requested.
SO I GOT THE VACINNE ON 1/13/21  THURSDAY 8 DAYS LATER I NOTICE A SMALL PEA SIZE BUMP IN THE ARM WHERE I GOT THE VACCINE.  SITE BEGAN TO ITCH AND IT EXPANDED  TO ABOUT 2 INCHES LONG, 1 INCH IN WIDTH, WARM TO THE TOUCH, ON FRIDAY MORNING THE I CHECKED AND IT EXPANDED EVEN MORE IT GOT TO 3 1/2 INCHES LONG WITH A 2 INCH WIDTH, VERY ITCHY VERY HOT AND IT IT WAS SWOLLEN WITH A BUMP.  I SHOWED COLLEAGUES AT WORKPLACE SINCE I AM AN HCP.  I HAVE PICTURES.  I CALLED MY DOCTORS OFFICE AND DID A ZOOM CONSULT MEETING AND GAVE HER ALL THE INFORMATION OF WHAT HAD HAPPENED.  SHE ASKED ME TO PLEASE REPORT THIS WITH THE CDC.
Tinnitus both ears.  It started approximately 2-3 days after Moderna Booster dose. This is a recurrence of the same adverse event after my second dose of the Moderna vaccine administered on 02/09/2021. The tinnitus started the week after the 2nd dose, and has been slowly resolving. After the 3rd booster dose of Moderna, the tinnitus has increased in intensity.
fever; body aches; Still doesn't feel well; Arm is also sore; This case was reported by a consumer via call center representative and described the occurrence of fever in a 58-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of malaise (received 1st dose at least 6 months ago, refer case US2020AMR062690). Concurrent medical conditions included nasal stuffiness (had a stuffy nose for the past few days before vaccination).   On 8th April 2020, the patient received the 2nd dose of Shingrix (intramuscular). On 8th April 2020, less than a day after receiving Shingrix, the patient experienced fever and general body pain. In April 2020, the patient experienced feeling unwell and pain in arm. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the fever, general body pain and pain in arm were not recovered/not resolved and the outcome of the feeling unwell was recovered/resolved.   It was unknown if the reporter considered the fever, general body pain, feeling unwell and pain in arm to be related to Shingrix.  Additional details were provided as follows: In the evening of vaccination day, the patient started experiencing fever and body aches. Less than a week after vaccination, the patient experienced feeling unwell and sore arm. The patient stated he still did not feel well in the morning of reporting day. The patient's arm was sore. The reporter consented to follow up.
This spontaneous report as received from a physician refers to a 17 years old male patient with amoxicillin allergy. The patient's medical history included recent ankle fracture. The patient was vaccinated with dose 1 GARDASIL around 15-JUN-2012. On 29-AUG-2012, the patient received second dose of GARDASIL (left deltoid). Concomitant medications included MINOCIN and LOVENOX. On 29-AUG-2012, the physician reported that his son received dose 2 of GARDASIL and that later that afternoon he developed papules near the site of injection. Later that same day, he developed generalized itching of his trunk with hives but his back and lower extremities were not affected. He had erythema on both arms. There was a maculopapular rash around his umbilicus and pubic area. The GARDASIL was administered by a Doctor who recommended the patient to be treated with BENADRYL and ZANTAC. No laboratory tests were performed. The physician said his son had no symptoms after receiving dose 1 of GARDASIL. The outcome of the events was reported as not recovered. The relatedness of the events with GARDASIL was unknown. Additional information has been requested.
Hx of cancer (no chemo), HTN, asthma, obesity. Initial onset: Headache, nausea and muscle aches within 30 minutes. She felt tightness in throat and difficulty breathing.  Unable to self-administer nebulizing treatment at home. Called 911 taken to ED via ambulance 11:45AM and discharged from ED at 9:00pm
feeling tired; cant open her eyes for few minutes, it's like eyelids are paralyzed; her eyelids dropped; Achy; fever; nausea; headache; A spontaneous report was received from consumer, concerning herself, a 65-year-old patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced a cant open her eyes for few minutes, it's like eyelids were paralyzed/ophthalmoplegia, her eyelids dropped/eyelid ptosis, achy/pain, fever/pyrexia, nausea, headache, feeling tired/fatigue.  The patient's medical procedure included corneal transplant and cataract surgery, historical condition included adverse reaction to a historical vaccine Hepatitis B vaccine. Concomitant medication was not reported.  On 04 March 2021, prior to onset of events, the patient received their first planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.  On 04 March 2021, soon after taking mRNA-1273 vaccine, patient was achy, fever, nausea, headache and feeling tired for 3 to 4 days. On 08 Mar 2021, patient's eyelids dropped, couldn't open her eyes for few minutes, it's like eyelids were paralyzed. The event eyelids were paralyzed was assessed as serious as per IME. This came on and off for 4 days. Treatment information was not provided.  Action taken with mRNA-1273 in response to the event was not reported.  The events patient's eyelids dropped, couldn't open her eyes for few minutes, it's like eyelids were paralyzed were resolved on 12-Mar-2021. The outcome of events achy, fever, nausea, headache and feeling tired was resolved on an unknown date.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The reporter stated that the patient was vaccinated with PEDVAXHIB (intramuscular, dose unknown) that was stored improperly on 19-JUN-2014. Pertinent medical history and concomitant medications were not reported. No adverse effects reported. The outcome of the events was unknown. No further information was provided. Additional information has been requested.
He asked if he could take Flonase or OTC nasal spray for his allergy; This is a spontaneous report was received from Pfizer sponsored program. A contactable male consumer (patient) reported for himself that: A male patient of unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/ Lot number and expiry date were not reported) via an unspecified route of administration on 01Mar2021 as single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient had previously received first dose of vaccine on 05Feb2021. In Mar2021, patient had nasal allergy and asked if he could take fluticasone propionate (FLONASE) or OTC nasal spray for his allergy. The outcome of event was unknown.  Information about batch/lot number has been requested.  Follow-up attempts completed. No further information expected.
received an adult bivalent dose administered more than 12 hours post puncture; No adverse event; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received an adult bivalent dose administered more than 12 hours post puncture) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (received an adult bivalent dose administered more than 12 hours post puncture) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (received an adult bivalent dose administered more than 12 hours post puncture) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (received an adult bivalent dose administered more than 12 hours post puncture).    Concomitant product use was not provided by the reporter. It was unknown if patient received any other vaccines in the 4 weeks prior to COVID-19 vaccine. HCP wanted to know why is it only 12 hours, the limit to administer a dose after the vial was punctured, and what happens to the dose itself HCP is investigating a possible scenario but nothing has been confirmed. There could be one individual that might have received an adult bivalent dose administered more than 12 hours post puncture. No treatment information was provided.   Reporter did not allow further contact